209 related articles for article (PubMed ID: 32035189)
1. Nanocarrier-mediated brain delivery of bioactives for treatment/prevention of neurodegenerative diseases.
Babazadeh A; Mohammadi Vahed F; Jafari SM
J Control Release; 2020 May; 321():211-221. PubMed ID: 32035189
[TBL] [Abstract][Full Text] [Related]
2. Nano-delivery systems for encapsulation of dietary polyphenols: An experimental approach for neurodegenerative diseases and brain tumors.
Squillaro T; Cimini A; Peluso G; Giordano A; Melone MAB
Biochem Pharmacol; 2018 Aug; 154():303-317. PubMed ID: 29803506
[TBL] [Abstract][Full Text] [Related]
3. Natural Bioactive Molecules as Neuromedicines for the Treatment/Prevention of Neurodegenerative Diseases.
Babazadeh A; Vahed FM; Liu Q; Siddiqui SA; Kharazmi MS; Jafari SM
ACS Omega; 2023 Jan; 8(4):3667-3683. PubMed ID: 36743024
[TBL] [Abstract][Full Text] [Related]
4. Adult-onset brain tumors and neurodegeneration: Are polyphenols protective?
Squillaro T; Schettino C; Sampaolo S; Galderisi U; Di Iorio G; Giordano A; Melone MAB
J Cell Physiol; 2018 May; 233(5):3955-3967. PubMed ID: 28884813
[TBL] [Abstract][Full Text] [Related]
5. Current insights on lipid nanocarrier-assisted drug delivery in the treatment of neurodegenerative diseases.
Teixeira MI; Lopes CM; Amaral MH; Costa PC
Eur J Pharm Biopharm; 2020 Apr; 149():192-217. PubMed ID: 31982574
[TBL] [Abstract][Full Text] [Related]
6. Antioxidant Effect of Flavonoids Present in Euterpe oleracea Martius and Neurodegenerative Diseases: A Literature Review.
de Oliveira NKS; Almeida MRS; Pontes FMM; Barcelos MP; de Paula da Silva CHT; Rosa JMC; Cruz RAS; da Silva Hage-Melim LI
Cent Nerv Syst Agents Med Chem; 2019; 19(2):75-99. PubMed ID: 31057125
[TBL] [Abstract][Full Text] [Related]
7. Lipid nanocarriers loaded with natural compounds: Potential new therapies for age related neurodegenerative diseases?
Soares TB; Loureiro L; Carvalho A; Oliveira MECDR; Dias A; Sarmento B; Lúcio M
Prog Neurobiol; 2018 Sep; 168():21-41. PubMed ID: 29641983
[TBL] [Abstract][Full Text] [Related]
8. Nanomedicine and its application in treatment of microglia-mediated neuroinflammation.
Baby N; Patnala R; Ling EA; Dheen ST
Curr Med Chem; 2014; 21(37):4215-26. PubMed ID: 25039775
[TBL] [Abstract][Full Text] [Related]
9. Nanotheranostic agents for neurodegenerative diseases.
Padmanabhan P; Palanivel M; Kumar A; Máthé D; Radda GK; Lim KL; Gulyás B
Emerg Top Life Sci; 2020 Dec; 4(6):645-675. PubMed ID: 33320185
[TBL] [Abstract][Full Text] [Related]
10. Dual effects of antioxidants in neurodegeneration: direct neuroprotection against oxidative stress and indirect protection via suppression of glia-mediated inflammation.
Wang JY; Wen LL; Huang YN; Chen YT; Ku MC
Curr Pharm Des; 2006; 12(27):3521-33. PubMed ID: 17017945
[TBL] [Abstract][Full Text] [Related]
11. Emerging Perspectives on Gene Therapy Delivery for Neurodegenerative and Neuromuscular Disorders.
Gomez Limia C; Baird M; Schwartz M; Saxena S; Meyer K; Wein N
J Pers Med; 2022 Nov; 12(12):. PubMed ID: 36556200
[TBL] [Abstract][Full Text] [Related]
12. Flavonoids as Potential Therapeutics Against Neurodegenerative Disorders: Unlocking the Prospects.
Faysal M; Dehbia Z; Zehravi M; Sweilam SH; Haque MA; Kumar KP; Chakole RD; Shelke SP; Sirikonda S; Nafady MH; Khan SL; Nainu F; Ahmad I; Emran TB
Neurochem Res; 2024 Jun; ():. PubMed ID: 38822985
[TBL] [Abstract][Full Text] [Related]
13. Bioactive Loaded Lipid-based Nanostructures: A Novel Insight for Age-related Neurodegeneration.
Srivastava R; Choudhury PK; Dev SK; Rathore V
Curr Mol Med; 2021; 21(9):724-794. PubMed ID: 33272174
[TBL] [Abstract][Full Text] [Related]
14. The role of genetics and gender specific differences in neurodegenerative disorders: Insights from molecular and immune landscape.
Hosseinzadeh S; Afshari S; Molaei S; Rezaei N; Dadkhah M
J Neuroimmunol; 2023 Nov; 384():578206. PubMed ID: 37813041
[TBL] [Abstract][Full Text] [Related]
15. Recent Updates on the Dynamic Association Between Oxidative Stress and Neurodegenerative Disorders.
Khan TA; Hassan I; Ahmad A; Perveen A; Aman S; Quddusi S; Alhazza IM; Ashraf GM; Aliev G
CNS Neurol Disord Drug Targets; 2016; 15(3):310-20. PubMed ID: 26831262
[TBL] [Abstract][Full Text] [Related]
16. The effects of vasoactive intestinal peptide in neurodegenerative disorders.
Deng G; Jin L
Neurol Res; 2017 Jan; 39(1):65-72. PubMed ID: 27786097
[TBL] [Abstract][Full Text] [Related]
17. Oxidative Stress and Antioxidants in Neurological Diseases: Is There Still Hope?
Carvalho AN; Firuzi O; Gama MJ; Horssen JV; Saso L
Curr Drug Targets; 2017 Mar; 18(6):705-718. PubMed ID: 27033198
[TBL] [Abstract][Full Text] [Related]
18. Nanoparticles in Combating Neuronal Dysregulated Signaling Pathways: Recent Approaches to the Nanoformulations of Phytochemicals and Synthetic Drugs Against Neurodegenerative Diseases.
Fakhri S; Abdian S; Zarneshan SN; Moradi SZ; Farzaei MH; Abdollahi M
Int J Nanomedicine; 2022; 17():299-331. PubMed ID: 35095273
[TBL] [Abstract][Full Text] [Related]
19. A network pharmacology study on the triterpene saponins from Medicago sativa L. for the treatment of Neurodegenerative diseases.
Liu XG; Lv MC; Huang MY; Sun YQ; Gao PY; Li DQ
J Food Biochem; 2019 Aug; 43(8):e12955. PubMed ID: 31368545
[TBL] [Abstract][Full Text] [Related]
20. Antioxidants and Nanotechnology: Promises and Limits of Potentially Disruptive Approaches in the Treatment of Central Nervous System Diseases.
Martinelli C; Pucci C; Battaglini M; Marino A; Ciofani G
Adv Healthc Mater; 2020 Feb; 9(3):e1901589. PubMed ID: 31854132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
